You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LATENT VIRAL INFECTION

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in Nairobi

Recruiting
  • HIV-1-infection
    • Nairobi, Kenya
      Kenya Medical Research Institute
    Jul 19, 2021

    HIV-1-infection, Methamphetamine-dependence Trial in San Francisco (Oral Methamphetamine, Placebo oral capsule)

    Recruiting
    • HIV-1-infection
    • Methamphetamine-dependence
    • Oral Methamphetamine
    • Placebo oral capsule
    • San Francisco, California
      San Francisco General Hospital
    Mar 22, 2022

    Latent Tuberculosis Infection in Health-care Workers and

    Recruiting
    • Tuberculosis
    • +4 more
    • Prevalence of Latent Tuberculosis Infection
    • Roma, Italy
      UOSD Allergologia e Immunologia Clinica, Fondazione Policlinico
    Mar 1, 2023

    Methods in People Living With Retroviral Infection in Liberia

    Active, not recruiting
    • Tuberculosis
    • HIV
      • Bethesda, Maryland
      • +4 more
      Jan 14, 2023

      Tuberculosis, Latent Tuberculosis Infection Trial in Bijie, Linping, Qingzhen (QuantiFERON-TB Gold (QFT) test)

      Recruiting
      • Tuberculosis
      • Latent Tuberculosis Infection
      • QuantiFERON-TB Gold (QFT) test
      • Bijie, Guizhou, China
      • +4 more
      Sep 12, 2023

      Latent Tuberculosis Trial (CDC/NTCA guidelines only, LTBI ASSIST and CDC/NTCA guidelines only)

      Not yet recruiting
      • Latent Tuberculosis
      • CDC/NTCA guidelines only
      • LTBI ASSIST and CDC/NTCA guidelines only
      • (no location specified)
      Mar 7, 2023

      Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis Trial in Malmö

      Recruiting
      • Latent Tuberculosis
      • +2 more
        • Malmö, Skåne, Sweden
          Skåne University Hospital
        Nov 10, 2022

        Latent Tuberculosis Infection Trial (Mycobacterium Vaccae for Injection)

        Not yet recruiting
        • Latent Tuberculosis Infection
        • Mycobacterium Vaccae for Injection
        • (no location specified)
        Dec 23, 2022

        HIV-1-infection Trial in Zurich (BCG Vaccine AJVaccines)

        Recruiting
        • HIV-1-infection
        • BCG Vaccine AJVaccines
        • Zurich, Switzerland
          University Hospital Zurich
        Jan 28, 2022

        Viral Upper Respiratory Tract Infection Trial (recombinant human interferon ? spray)

        Not yet recruiting
        • Viral Upper Respiratory Tract Infection
        • recombinant human interferon ω spray
        • (no location specified)
        May 7, 2023

        Viral Infection, Sepsis Trial in Limoges (Blood sample)

        Not yet recruiting
        • Viral Infection
        • Sepsis
        • Blood sample
        • Limoges, France
          Limoges University Hospital
        Jan 2, 2023

        Respiferon Project

        Recruiting
        • Respiratory Viral Infection
        • Evaluate the performance of IFN I/III
        • Lyon, Rhone, France
          Infective Agents Institute, Croix rousse Hospital
        Aug 24, 2023

        Latent Tuberculosis Infection Trial in Taipei (isoniazid and rifapentine)

        Recruiting
        • Latent Tuberculosis Infection
        • isoniazid and rifapentine
        • Taipei, Taiwan
          National Taiwan University Hospital
        Nov 22, 2022

        Latent Tuberculosis, Diabete Mellitus, Malnutrition Trial in Chennai

        Recruiting
        • Latent Tuberculosis
        • +3 more
          • Chennai, Tamilnadu, India
            National Institute for Research in Tuberculosis
          Jul 6, 2022

          Pulmonology Trial in Taipei (Rifamycin-containing regimen, Rifamycin-free regimen)

          Recruiting
          • Pulmonology
          • Rifamycin-containing regimen
          • Rifamycin-free regimen
          • Taipei, Taiwan
            National Taiwan University Hospital
          Oct 18, 2022

          Microbial Colonization, Viral Infection, Neonatal Infection Trial in Caen (Nasal swab)

          Recruiting
          • Microbial Colonization
          • +2 more
          • Nasal swab
          • Caen, France
            CAEN University Hospital
          Feb 10, 2023

          Infectious Viral Load: a Prospective Observational Study

          Recruiting
          • SARS-CoV-2 Infection
          • +3 more
          • No intervention
          • Geneva, Switzerland
            Geneva University Hospital
          Mar 20, 2023

          Discover Immune Signature of Sepsis Caused by Acute Pulmonary

          Not yet recruiting
          • Sepsis
          • +3 more
          • pathogen
          • Beijing, Beijing, China
            China-Japan Friendship Hospital
          Nov 8, 2022

          Latent Tuberculosis Trial in Baltimore (Usual Care, Video Directly Observed Therapy alone, Video Directly Observed Therapy plus

          Recruiting
          • Latent Tuberculosis
          • Usual Care
          • +2 more
          • Baltimore, Maryland
            Baltimore City Health Department
          Feb 8, 2022

          INVESTIGATE THE ASSOCIATION BETWEEN VIRAL NEUROTOXIC INFECTION

          Not yet recruiting
          • POSTOPERATIVE DELIRIUM AND POSTOPERATIVE COGNITIVE DECLINE
          • Virological screening
          • (no location specified)
          Mar 28, 2023

          COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection, Rhinovirus Trial (Vapendavir, Placebo)

          Not yet recruiting
          • COPD Exacerbation Acute
          • +35 more
          • (no location specified)
          Nov 20, 2023

          Tuberculosis, HIV Trial (Dolutegravir, 3HP)

          Not yet recruiting
          • Tuberculosis
          • HIV
          • (no location specified)
          Dec 9, 2022

          s From HIV Infection, KSHV Infection, Viral-Related

          Recruiting
          • HIV
          • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 25, 2023

            Long COVID-19, Long COVID Trial (Paxlovid 25 day dosing, Paxlovid 15 day dosing, Control)

            Not yet recruiting
            • Long COVID-19
            • Long COVID
            • Paxlovid 25 day dosing
            • +2 more
            • (no location specified)
            Jul 25, 2023

            Infectious Disease Trial in Poriyya (VOX)

            Not yet recruiting
            • Infectious Disease
            • VOX
            • Poriyya, Israel
              Poriya Medical Center
            Aug 8, 2022